NAV
$78.27
AUM
$9.1B
Expense Ratio
-
Dividend Yield
2.90%
Beta
0.89
Currency
USD
| YTD | 1M | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|
| +7.03% | +2.68% | +6.62% | +16.74% | +17.19% | +9.81% |
| # | Symbol | Name | Weight |
|---|---|---|---|
| 1 | ASML.AS | ASML Holding NV | 4.61% |
| 2 | HSBA.L | HSBC Holdings PLC | 2.37% |
| 3 | ROP.SW | Roche Holding AG Ordinary Shares new | 2.13% |
| 4 | AZN.L | AstraZeneca PLC | 2.11% |
| 5 | NOVN.SW | Novartis AG Registered Shares | 2.11% |
| 6 | NESN.SW | Nestle SA | 1.91% |
| 7 | SHEL.L | Shell PLC | 1.76% |
| 8 | SIE.DE | Siemens AG | 1.69% |
| 9 | SAP.DE | SAP SE | 1.37% |
| 10 | SAN.MC | Banco Santander SA | 1.34% |
The fund will invest at least 80% of its assets in securities included in the underlying index. The underlying index is a free float adjusted market capitalization-weighted index which consists of equity securities from developed European countries or regions, including: Austria, Belgium, Denmark, Finland, France, Germany, Ireland, Italy, the Netherlands, Norway, Portugal, Spain, Sweden, Switzerland and the United Kingdom.
Inception Date: 2018-06-15